Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments....
UK-based The Rodnight Partnership ties up with India's Pluss...
Affirms Strong Performance and Focus on India Amidst Ongoing Expansion...
Brings Delhi’s first-ever comprehensive preventive health solution called Smart Gene Plan ...
Extending high-quality testing services to patients with latest & innovative diagnostic technologies...
Marking the 50-year bilateral diplomatic relations between Korea and Nepal...
hrough this partnership, Strive Health, Prominence Health Plan and Sierra Nevada Specialty Care will bring high-quality care to patients with kidney disease across Nevada...
Genea Fertility is pleased to announce Melbourne Fertility Specialist Dr Catarina Ang is joining the world-leading fertility provider. Dr Ang, an experienced gynaecologist and obstetrician, will consult from Genea Fertility's new Melbourne City clinic, which is set to open its doors in September....
Representing one of the largest investments in the eye care services space...
To drive further advancements in healthcare technology and foster transformative innovation in patient care...
